United Asset Strategies Inc. Trims Position in Cigna Group $CI

United Asset Strategies Inc. cut its stake in shares of Cigna Group (NYSE:CI) by 97.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,131 shares of the health services provider’s stock after selling 42,106 shares during the period. United Asset Strategies Inc.’s holdings in Cigna Group were worth $326,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Massachusetts Financial Services Co. MA increased its holdings in Cigna Group by 1.1% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after acquiring an additional 123,479 shares during the period. Dodge & Cox grew its position in shares of Cigna Group by 0.7% during the 2nd quarter. Dodge & Cox now owns 8,950,610 shares of the health services provider’s stock valued at $2,958,893,000 after purchasing an additional 60,877 shares in the last quarter. Valeo Financial Advisors LLC grew its position in shares of Cigna Group by 86,071.1% during the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares in the last quarter. Norges Bank bought a new position in shares of Cigna Group in the second quarter worth $1,110,426,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock worth $829,339,000 after buying an additional 492,045 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Up 1.7%

Shares of CI opened at $283.97 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76. The stock has a 50 day simple moving average of $271.62 and a two-hundred day simple moving average of $289.39. The firm has a market cap of $75.86 billion, a P/E ratio of 12.53, a P/E/G ratio of 0.98 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. During the same period in the previous year, the business posted $7.51 EPS. The business’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.1%. The ex-dividend date was Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 26.64%.

Insider Activity

In related news, CEO David Cordani acquired 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were purchased at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on CI shares. Robert W. Baird reduced their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Cowen set a $333.00 price objective on Cigna Group in a report on Monday, December 15th. Jefferies Financial Group restated a “buy” rating and issued a $310.00 price objective on shares of Cigna Group in a research report on Monday, November 3rd. Wells Fargo & Company dropped their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a research report on Wednesday, November 5th. Finally, Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Sunday, December 28th. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $333.04.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.